Prevalence of hypertension among antiretroviral therapy naïve patients in Lagos, Nigeria
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background The gains from successful antiretroviral therapy (ART) roll-out could be compromised by the increasing burden of non-communicable diseases, particularly cardiovascular diseases among people living with HIV (PLWH). Hypertension remains a significant contributor to cardiovascular diseases. This study aims to determine the prevalence and determinants of hypertension among ART-naïve PLWH in a large ART clinic in Lagos, Nigeria. Materials and methods This study uses data collected from adult ART-naïve PLWH enrolled at an ART clinic over ten years. Participants aged 18 years and older, not pregnant, and not accessing care for post-exposure prophylaxis were included in the study. Hypertension was defined as systolic and diastolic blood pressure greater than or equal to 140 mmHg and 90 mmHg, respectively. Logistic regressions were used to investigate the factors associated with hypertension. Results Among the 10 426 participants included in the study, the majority were females (66%) and aged 25—49 years (84%). The crude prevalence of hypertension was 16.8% (95%CI 16.4 – 17.2) while the age and sex standardised prevalence rate was 21.9% (95%CI 20.7 – 23.2), with males (25.8%, 95%CI 23.5 – 28.0) having a higher burden compared with females (18.3%, 95%CI 17.0 – 19.6). Increasing age, male gender, overweight or obesity, comorbid diabetes mellitus or renal disease, and CD4 count ≥ 201 cells/μL were significantly associated with prevalent hypertension. Conclusion There was a substantial burden of hypertension among ART-naïve PLWH, which was associated with the traditional risk factors of the condition. This highlights the need to integrate screening and care of hypertension into routine HIV management for optimal care of PLWH.
Abstract
Background The gains from successful antiretroviral therapy (ART) roll-out could be compromised by the increasing burden of non-communicable diseases, particularly cardiovascular diseases among people living with HIV (PLWH). Hypertension remains a significant contributor to cardiovascular diseases. This study aims to determine the prevalence and determinants of hypertension among ART-naïve PLWH in a large ART clinic in Lagos, Nigeria. Materials and methods This study uses data collected from adult ART-naïve PLWH enrolled at an ART clinic over ten years. Participants aged 18 years and older, not pregnant, and not accessing care for post-exposure prophylaxis were included in the study. Hypertension was defined as systolic and diastolic blood pressure greater than or equal to 140 mmHg and 90 mmHg, respectively. Logistic regressions were used to investigate the factors associated with hypertension. Results Among the 10 426 participants included in the study, the majority were females (66%) and aged 25—49 years (84%). The crude prevalence of hypertension was 16.8% (95%CI 16.4 – 17.2) while the age and sex standardised prevalence rate was 21.9% (95%CI 20.7 – 23.2), with males (25.8%, 95%CI 23.5 – 28.0) having a higher burden compared with females (18.3%, 95%CI 17.0 – 19.6). Increasing age, male gender, overweight or obesity, comorbid diabetes mellitus or renal disease, and CD4 count ≥ 201 cells/μL were significantly associated with prevalent hypertension. Conclusion There was a substantial burden of hypertension among ART-naïve PLWH, which was associated with the traditional risk factors of the condition. This highlights the need to integrate screening and care of hypertension into routine HIV management for optimal care of PLWH.
참고문헌 (57)
- Hill A, "HIV treatment cascades : How can all countries reach the UNAIDS 90–90-90 target?", AIDS, 29, pp.2523~2525 (2015)
- "HIV - Number of people dying from HIV-related causes" (2023)[URL]
- "HIV and AIDS in Nigeria | Avert" (2019)[URL]
- Girum T, "Trend of HIV", AIDS for the last 26 years and predicting achievement of the 90–90-90 HIV prevention targets by 2020in Ethiopia : a time series analysis, 2018, pp.18, 320~
- Achwoka D, "Tackling an emerging epidemic : The burden of non-communicable diseases among people living with hiv", aids in Sub-Saharan Africa, 2020, pp.36, 1~9
- Achwoka D, "High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya", PLoS One, 15, pp.e0235606~ (2020)[DOI]
- Smit M, "The growing burden of noncommunicable disease among persons living with HIV in Zimbabwe", AIDS, 32, pp.773~782 (2018)[DOI]
- De Von HA, "The significance of HIV and non-communicable diseases in Africa", Rwanda J Med Heal Sci, 1, pp.43~45 (2018)
- Belaunzaran-Zamudio PF, "Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America", PLoS One, 15 (2020)[DOI]
- "Noncommunicable diseases" (2019)[URL]
- High KP, "HIV and aging : state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group", J Acquir Immune Defic Syndr, 60(Suppl 1), pp.S1~S18 (2012)[DOI]
- Bigna JJ, "Global burden of hypertension among people living with HIV in the era of increased life expectancy : a systematic review and meta-analysis", J Hypertens, 38, pp.1659~1668 (2020)
- Okello S, "Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa", Prog Cardiovasc Dis, 63, pp.149~159 (2020)
- Gonah L, "Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe", African J Prim Heal Care Fam Med, 12(1), pp.1~6 (2020)
- Gonah L, "Effects of HIV and non-communicable disease comorbidity on healthcare costs and health experiences in people living with HIV in Zimbabwe", South Afr J HIV Med, 21 (2020)
- Shiri T, "Patient and health provider costs of integrated HIV, diabetes and hypertension ambulatory health services in low-income settings — an empirical socio-economic cohort study in Tanzania and Uganda", BMC Med, 19, pp.1~15 (2021)[DOI]
- Badejo OA, "Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria : A national survey", PLoS One, 13 (2018)[DOI]
- "Global HIV & AIDS statistics — 2020 fact sheet" (2021)[URL]
- Isa SE, "Hypertension in treated and untreated patients with HIV : A study from 2011 to 2013 at the Jos University Teaching Hospital, Nigeria", Trans R Soc Trop Med Hyg, 111, pp.172~177 (2017)[DOI]
- Denue BA, "Effects of highly active antiretroviral therapy(HAART)on blood pressure changes and its associated factors in HAART naive HIV-infected patients in north eastern Nigeria", Arch Appl Sci Res, 4, pp.1447~1452 (2012)
- Ilesanmi OS, "Prevalence and risk factors of hypertension in HIVpositive adults on antiretroviral therapy in Ondo State", Nigeria HIV AIDS Rev, 19, pp.199~205 (2020)[DOI]
- Muhammad S, "Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy", Niger Med J, 54, pp.185~ (2013)
- Ekrikpo UE, "Prevalence and correlates of chronic kidney disease(CKD)among ART-naive HIV patients in the Niger-Delta region of Nigeria", Med(United States), 97, pp.1~6 (2018)
- Dakum P, "Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus", Medicine(Baltimore), 98, pp.e15024~ (2019)[DOI]
- Aridegbe M, "Obesity, hypertension, and dyslipidemia among human immunodeficiency virus patients in Abeokuta Ogun State", Nigeria Niger J Cardiol, 16, pp.83~ (2019)[DOI]
- Federal Ministry of Health Nigeria, "National Guidelines for HIV Prevention Treatment and Care (2016)", ~ (2016)
- Weinberg JL, "The WHO Clinical Staging System for HIV", AIDS, 2010, pp.12, 202~206
- Unger T, "2020 International Society of Hypertension Global Hypertension Practice Guidelines", Hypertension, 75, pp.1334~1357 (2020)
- "National Policy on Education" (2011)[URL]
- "Alcohol use disorders identification test consumption (AUDIT C)" (2017)[URL]
- Kwaghe AV, "Evaluation of the national tuberculosis surveillance and response systems, 2018 to 2019: National tuberculosis, leprosy and buruli ulcer control programme, Abuja, Nigeria", Pan Afr Med J, 35 (2020)[DOI]
- "The National Strategic Plan for Tuberculosis and Leprosy Control (2010–2015)" (2011)[URL]
- "Obesity: Preventing and Managing the Global Epidemic" (2000)[URL]
- "People living with HIV who have suppressed viral loads" (2020)[URL]
- "Terms, Definitions, and Calculations Used in CDC HIV Surveillance Publications" (2016)[URL]
- Vajpayee M, "CDC staging based on absolute CD 4 count and CD 4 percentage in an HIV-1-infected Indian population : treatment implications", Clin Exp Immunol, 141, pp.485~490 (2005)
- Guwatudde D, "The burden of hypertension in sub-Saharan Africa : A four-country cross sectional study", BMC Public Health, 15, pp.1~8 (2015)
- Kagaruki GB, "Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania : A cross sectional study from Mbeya and Dar es Salaam regions", BMC Public Health, 14, pp.904~ (2014)
- Pase MP, "Dietary approaches to reduce aortic stiffness" (2016), Elsevier Inc
- NATIONAL MULTI-SECTORAL ACTION PLAN FOR THE NON-COMMUNICABLE DISEASES, "Federal Ministry of Health Nigeria", ~ (2019)
- RodrõÂguez-ArbolõÂ E, "Incidence and risk factors for hypertension among HIV patients in rural Tanzania-A prospective cohort study", PLoS ONE, 12, pp.1~14 (2017)[DOI]
- Kato I, "Prevalence of non-communicable diseases among individuals with HIV infection by antiretroviral therapy status in Dar es Salaam, Tanzania", PLoS One, 15, pp.e0235542~ (2020)[DOI]
- Peck RN, "Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults : A cross-sectional study", BMC Med, 12, pp.125~ (2014)[DOI]
- Kwarisiima D, "Population-based assessment of hypertension epidemiology and risk factors among HIV-positive and general populations in rural Uganda", PLoS One, 11(5), pp.e0156309~ (2016)
- Xu Y, "Global prevalence of hypertension among people living with HIV : a systematic review and meta-analysis", J Am Soc Hypertens, 11, pp.530~540 (2017)[DOI]
- Dimala CA, "Association between CD4 Cell Count and Blood Pressure and Its Variation with Body Mass Index Categories in HIV-Infected Patients", Int J Hypertens, 2018 (2018)[DOI]
- Masenga SK, "Patho-immune Mechanisms of Hypertension in HIV : a Systematic and Thematic Review", Curr Hypertens Rep, 21, pp.1~9 (2019)
- Lai SW, "Population-based cohort study examining the association between weight loss and pulmonary tuberculosis in adults", Biomed, 8, pp.41~46 (2018)
- Shah M, "Latent tuberculosis infection", N Engl J Med, 385, pp.2271~2280 (2021)
- Tegegne KD, "Incidence and Predictors of Opportunistic Infections Among Adult HIV Infected Patients on Anti-Retroviral Therapy at Dessie Comprehensive Specialized Hospital, Ethiopia : A Retrospective Follow-Up Study", HIV, 2022, pp.14, 195~206
- Ramesh K, "Clinical profile of human immunodeficiency virus patients with opportunistic infections : A descriptive case series study", Int J Appl Basic Med Res, 5, pp.119~123 (2015)
- "Be in the Know. At a glance: HIV in Nigeria | Be in the Know 2023"[URL]
- Bethany E, "Gender differences in hypertension among young adults", HHS Public Access, 61, pp.1~17 (2016)
- Zhang Y, "Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999to 2014", Hypertension, 70, pp.736~742 (2017)
- Reckelhoff JF, "Gender differences in hypertension", Curr Opin Nephrol Hypertens, 27, pp.176~181 (2018)
- Hilliard LM, "The"his and hers"of the renin-angiotensin system", Curr Hypertens Rep, 15, pp.71~79 (2013)[DOI]